x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases

AD/PD™ on UNLOK

AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer"s, Parkinson’s, and related neurodegenerative diseases. The "AD/PD™ Session Spotlight" series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes. Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the future of

science life sciences

All Episodes

00:39:27

Therapy for AD, PD & LBD: Translational Models,...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/10/16

In this episode, we spotlight Forum Discussion 06 from the AD/PD™ 2025 International Conference — “Therapy for AD, PD & LBD: Novel Translational Models, New Receptor- and Neuroinflammation-Based Targets – How Close Are We to Success?”The session was moderated by Prof. Gabriel Gold (Switzerland) and Dr. Meg Smith (USA), with contributions from Dr. Pablo Sardi (USA), Prof. Michael Heneka (Luxembourg), Prof. Thomas Südhof (USA), Dr. Taylor Schmitz (Canada), Prof. Frank Longo (USA), and Dr. Cynthia

en

00:17:43

Pivotal Points in Prevention Trials and the New Era...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/10/02

In this episode, we spotlight Plenary Lecture 06 from the AD/PD™ 2025 International Conference — “Pivotal Points in Prevention Trials and the New Era of Precision Medicine for Alzheimer’s Disease and Related Disorders.”The session was chaired by Prof. Gabriel Gold (Switzerland), with the lecture delivered by Prof. Miia Kivipelto (Sweden), an internationally recognized leader in dementia prevention research.Key highlights include:• Results from the landmark FINGER study and the global expansion

en

00:17:53

Novel Approaches to Accelerate Development of...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/09/12

In this episode, we spotlight Forum Discussion 5 from the AD/PD™ 2025 International Conference — “Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies Linked to PD, LBD, and MSA.”Moderated by Dr. Jamie Eberling (USA) and Dr. Ken Marek (USA), the discussion brought together leading experts: Prof. Fabrizio Stocchi (Italy), Prof. Amos Korczyn (Israel), Dr. Tomislav Babic (Austria), Dr. Maria Maccecchini (USA), Dr. Robert Drolet

en

00:15:05

Pathogenic Mechanisms of Familial AD and Emerging...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/08/21

In this episode, we highlight Plenary Lecture 05 from the AD/PD™ 2025 International Conference — “Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developments.”Chaired by Prof. Manfred Windisch (Austria), the lecture was delivered by Prof. Jie Shen (USA), a leading neurologist from Harvard Medical School whose pioneering research has transformed our understanding of familial Alzheimer’s disease (FAD) and its underlying molecular mechanisms.Key highlights include:• The Preclin

en

00:24:08

Translational Drug Development in AD: Promising...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/07/31

In this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™ 2025 International Conference — “Translational Drug Development in AD (Phase I–III) and Relevance for Treatment and Disease Modification: What Could Be Promising Strategies? Small Molecules for Symptomatic & Disease Modification.”Moderated by Dr. Jeffrey Cummings (USA) and Dr. Howard Fillit (USA), this forward-looking discussion brought together leaders in drug development and clinical research, including Prof

en

00:21:55

Treatment of DLB and PDD: Status and New...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/07/24

In this episode, we feature Plenary Lecture 04 from the AD/PD™ 2025 International Conference — the Eric N. Birch Memorial Lecture, titled “Treatment of DLB and PDD: Status and New Developments.”Chaired by Dr. Sandra Moose (USA) and presented by Prof. Dag Aarsland (UK), this important plenary cast a spotlight on two often-overlooked conditions in the neurodegenerative disease landscape: Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD).Prof. Aarsland delivered a comprehensive

en

00:17:13

Improving the Therapeutic Potential of...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/07/10

In this episode, we spotlight Forum Discussion 03 from the AD/PD™ 2025 International Conference: “Improving the Therapeutic Potential of Immunotherapies in AD – Can Novel Strategies or Next Generation Drugs Halt or Further Delay Disease Progression?”Chaired by Dr. Rudolph Tanzi (USA) and Dr. Suzanne Hendrix (USA), this thought-provoking panel brought together leaders in Alzheimer’s disease research and development: Dr. Chad Swanson, Dr. Donna Wilcock, Dr. Yuval Zabar, Dr. Janice Smith, and Dr. Eric

en

00:23:40

GLP-1R Agonist Effects in the Brain: Exploring...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/07/03

In this episode, we explore Plenary Lecture 2 from the AD/PD™ 2025 International Conference: “GLP-1R Agonist Effects in Brain.”Moderated by Dr. Cynthia Lemere (USA) and Dr. Henrietta Nielsen (Sweden), this featured lecture was presented by Dr. Lotte Bjerre Knudsen (Denmark), Chief Scientific Advisor at Novo Nordisk. A pioneering force in GLP-1 drug development and co-inventor of liraglutide, Dr. Knudsen shared novel data on semaglutide’s potential neuroprotective mechanisms, as the drug advances

en

00:20:13

Integrating Blood-Based, CSF and Imaging Biomarkers...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/06/19

In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — Forum Discussion 2, "Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and AI in MCI & AD."Moderated by Dr. Oskar Hansson (Sweden) and Dr. Melissa Murray (USA), this dynamic session was led by Dr. Rhoda Au (USA), Prof. Charlotte Teunissen (Netherlands), Dr. Danielle Graham (USA), Dr. Bryan Cobb (USA) and Dr. Tobias Bittner (Switzerland). The discussion

en

00:15:05

The Alzheimer's Disease Drug Development Pipeline:...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/06/05

In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ 2025, titled "The Alzheimer's Disease Drug Development Pipeline: Observations and Implications," delivered by Dr. Jeffrey Cummings (USA) and chaired by Dr. Cynthia Lemere (USA) and Dr. Henrietta Nielsen (Sweden).Renowned for his leadership in Alzheimer’s research, Dr. Cummings offers a sweeping and data-driven overview of the evolving landscape of Alzheimer’s drug development—spotlighting trends,

en

00:17:14

Plasma Biomarkers for Dementias in the Era of...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/05/22

In episode 2 of AD/PD™ Session Spotlight, we feature Plenary Lecture 3, the Don Price Memorial Lecture, titled "Plasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies," presented by Prof. Charlotte Teunissen (The Netherlands) and chaired by Dr. Sangram Sisodia (USA).This compelling lecture honors the legacy of Dr. Donald L. Price and explores the transformative role of plasma biomarkers in Alzheimer’s disease care, from diagnosis to personalized treatment strategies.Key highlights

en

00:18:03

Varying Regulatory Philosophies and AD Approval...

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/05/14

In this episode of AD/PD™ Session Spotlight, we delve into Forum Discussion 1, "Varying Regulatory Philosophies and AD Approval Priorities – USA, EU, Asia, and Other Parts of the World," a dynamic exchange exploring how regional regulatory approaches impact the development, approval, and accessibility of Alzheimer’s disease therapies.Co-moderated by Agneta Nordberg (Sweden) and David Holtzman (USA), this discussion brings together insights from international regulatory and clinical

en

00:01:38

Welcome to the AD/PD™ Session Spotlight

The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and... ·

2025/04/17

Welcome to AD/PD™ Session Spotlight, an official podcast series by AD/PD™. The podcast will discuss the latest cutting-edge science and real-world clinical impact in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases, presented at the AD/PD™ 2025 Conference.This AI-generated series is built for medical professionals and researchers who want to stay current with the latest breakthroughs without missing a step. Each episode offers concise, curated summaries of key sessions from the

en

13 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter